
Program Launch: February 26, 2021 Program Expiration: August 26, 2021
Program Learning Objectives:
- Provide an overview on nmCRPC, the initial phase of advanced prostate cancer
- Review the efficacy for a nmCRPC treatment option including new overall survival data
- View updated safety data from the final analysis for a treatment in nmCRPC
- Learn about other clinical considerations when prescribing a treatment option in nmCRPC
- Review key data and clinical considerations for a nmCRPC treatment option
Speakers:
|